Literature DB >> 19400810

Septic arthritis and acute hematogenous osteomyelitis in childhood at a tertiary hospital in Japan.

Yoshiaki Yamagishi1, Masao Togawa, Masashi Shiomi.   

Abstract

BACKGROUND: The aim of the present study was to describe the clinical features of septic arthritis (SA) and acute hematogenous osteomyelitis (AHO) in children and to assess the impact of health-care-associated infections and antimicrobial resistance.
METHODS: A retrospective review of medical records of children presenting to Osaka City General Hospital with SA and AHO was undertaken during an 85 month period. The following data were assessed: location at onset, age and gender, risk factors, involved joints and/or bones, symptoms and time of presentation, causative agents and sensitivity to antibiotics, treatments and late complications.
RESULTS: There were four health-care-associated (HCAI) and 20 community-acquired infections (CAI). The latency period from initial presentation to diagnosis was relatively longer in HCAI than CAI. The most common pathogen was methicillin-resistant Staphylococcus aureus (MRSA). Twenty percent of CAI patients and half of the HCAI patients were treated empirically for MRSA. All patients with complications had MRSA infection.
CONCLUSION: Many pediatric patients with SA were not treated initially with optimal antibiotics. Although surgical intervention was almost inevitably required, selection and administration of effective antibiotics was necessary not only to cure the current infection but also to prevent metastatic infection. In Japan, empiric treatment of SA and AHO should include first-line antibiotics against MRSA.

Entities:  

Mesh:

Year:  2008        PMID: 19400810     DOI: 10.1111/j.1442-200X.2008.02740.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  8 in total

1.  The recent bacterial etiology of childhood osteoarticular infections focusing on the vaccine initiation for Streptococcus pneumoniae and Haemophilus influenzae: A single-center retrospective analysis in Japan.

Authors:  Kengo Kawaguchi; Tomoyuki Nakamura; Akifusa Wada; Kazuyuki Takamura; Haruhisa Yanagida; Toru Yamaguchi
Journal:  J Orthop       Date:  2022-03-08

2.  Revisiting Methicillin-Resistant Staphylococcus aureus Infections.

Authors:  Abdelkarim Waness
Journal:  J Glob Infect Dis       Date:  2010-01

Review 3.  Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review.

Authors:  K Z Vardakas; I Kontopidis; I D Gkegkes; P I Rafailidis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-20       Impact factor: 3.267

Review 4.  Global epidemiology of childhood bone and joint infection: a systematic review.

Authors:  Sarah Hunter; Heidi Chan; Joseph F Baker
Journal:  Infection       Date:  2022-01-20       Impact factor: 3.553

5.  The epidemiology of pediatric bone and joint infections in Cambodia, 2007-11.

Authors:  Nicole Stoesser; Joanna Pocock; Catrin E Moore; Sona Soeng; PutChhat Hor; Poda Sar; Direk Limmathurotsakul; Nicholas Day; Varun Kumar; Sophy Khan; Vuthy Sar; Christopher M Parry
Journal:  J Trop Pediatr       Date:  2012-09-13       Impact factor: 1.165

6.  Clinical and epidemiological characteristics of septic arthritis of the hip, 2006 to 2012, a seven-year review.

Authors:  Helder de Souza Miyahara; Camilo Partezani Helito; Guilherme Batista Oliva; Paulo César Aita; Alberto Tesconi Croci; José Ricardo Negreiros Vicente
Journal:  Clinics (Sao Paulo)       Date:  2014-07       Impact factor: 2.365

7.  Prognostic factors of septic arthritis of hip in infants and neonates: minimum 5-year follow-up.

Authors:  Soon Chul Lee; Jong Sup Shim; Sung Wook Seo; Sung San Lee
Journal:  Clin Orthop Surg       Date:  2015-02-10

8.  Clinical and epidemiological differences between septic arthritis of the knee and hip caused by oxacillin-sensitive and -resistant s. aureus.

Authors:  Camilo Partezani Helito; Bruno Bonganha Zanon; Helder de Souza Miyahara; Jose Ricardo Pecora; Ana Lucia Munhoz Lima; Priscila Rosalba de Oliveira; Jose Ricardo Negreiros de Vicente; Marco Kawamura Demange; Gilberto Luis Camanho
Journal:  Clinics (Sao Paulo)       Date:  2015-01       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.